Pharmaceuticals News

Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.

Pharma Industry's Capacity to Produce Cytotoxic Injectable Drugs Constricts

PharmSource special report shows demand could tap existing CMO capacity. - June 27, 2014 - PharmSource

Q1 Productions Hosting First-Ever Pharmaceutical Supplier Quality Assurance Conference in Arlington

Supplier Visibility, Balancing Quality and Budgets Among Session Topics - June 27, 2014 - Q1 Productions

Serialization a Hot Topic at Upcoming Pharmaceutical Supply Chain Management Conference

Impending Serialization Requirements and End-to-End Visibility Major Discussion Focus at Second Annual Meeting - June 26, 2014 - Q1 Productions

Mayne Pharma Appoints Blake Cullen VP Business Development for U.S. Generics

He brings 15+ years of pharma industry experience in strategic planning, mergers and acquisitions, and product in-licensing and out-licensing. - June 16, 2014 - Mayne Pharma USA

Insulin Market Expected to Reach USD 32,346.7 Million in 2018 - Transparency Market Research

Transparency Market Research includes new market research report “Insulin Market" to its huge collection of research reports. - June 15, 2014 - Transparency Market Research

PlanetRx Celebrates Successful Re-Launch

PlanetRx has demonstrated improved customer satisfaction ratings with timely order fulfillment and increased offerings aimed at improving customers’ healthy lifestyles. - June 13, 2014 - PlanetRX

Markus Pompejus, VP at BASF, to Keynote at Biobased Chemicals Conf. (Sep 18-19, 2014 San Francisco)

Markus Pompejus, Vice President at BASF to Give Keynote Presentation at 5th Biobased Chemicals Commercialization & Partnering Conference (Sep 18-19, 2014 in San Francisco, CA) - June 13, 2014 - GTCbio

Photetica® Will do to the Medical Industry What Elon Musk and Tesla (TSLA) Did to the Automotive Industry

Photetica® Will do to the Medical Industry What Elon Musk and Tesla (TSLA) Did to the Automotive Industry

Photetica is now in the clinical trial phase with its game changing medical technology designed to prevent and reverse chemotherapy side effects during chemotherapy treatment at a Rochester, Minnesota based Oncology research and treatment center. - June 12, 2014 - Photetica

IonSense Introduces the DART®-EDU Program to Provide Educational Institutions with an Economical Path to Ownership of Its State-of-the-Art Mass Spectrometry Technology

Educational Leasing Program will enable chemistry departments to lower operating costs while providing students access to Direct Analysis in Real Time Mass Spectrometry. To be exhibited at the 62nd ASMS Conference on Mass Spectrometry and Allied Topics in Baltimore, MD, June 15-19, 2014, Booth 120. - June 10, 2014 - IonSense, Inc.

Strathmore’s Who’s Who Honors John T. Spitznagel as Professional of the Year

Strathmore’s Who’s Who Honors John T. Spitznagel as Professional of the Year

John T. Spitznagel has recently been recognized by Strathmore’s Who’s Who Registry for his outstanding contributions and achievements in the field of Healthcare Sales and Marketing. - June 06, 2014 - Strathmore Who's Who

Linda N. Bishop Recognized by Strathmore's Who's Who Worldwide Publication

Linda N. Bishop of Winter Haven, Florida has been included in the Strathmore’s Who’s Who Worldwide Edition for her outstanding contributions and achievements in the field of healthcare. About Linda N. Bishop Ms. Bishop has over 26 years experience in the healthcare field. She is a CRPT... - June 06, 2014 - Strathmore Worldwide

Recursion Pharmaceuticals Announces Dr. H. Perry Fell as the First Member of Business Advisory Panel

Recursion Pharmaceuticals, a biotech start-up in Salt Lake City today announced the formation of its Business Advisory Panel. The first appointment to the Advisory Panel is H. Perry Fell, MBA, Ph.D. Perry is a distinguished scientist and leader who most prominently co-founded Seattle Genetics (NASDAQ: SGEN) and served as its CEO from start-up through IPO. - June 05, 2014 - Recursion Pharmaceuticals

Solvo Biotechnology, the Transporter Company and Qualyst Transporter Solutions Execute a License to B-Clear® Services

Agreement Supporting Use of Qualyst’ s Patented B-CLEAR® Technology for Services offered by Solvo Biotechnology - May 29, 2014 - Solvo Biotechnology

Life Science Strategy Group Launches the OutsourcePharma Advisory Board

Online community dedicated to pharmaceutical sponsors provides open forum to discuss drug development and outsourced Contract Research Organization (CRO) services. - May 28, 2014 - Life Science Strategy Group, LLC

Jane Rohlf, MD & Premier Research Join Wake Research: New Investigational Site Added to Established Organization of Integrated Clinical Research Investigational Site

Raleigh-based Wake Research (Wake Research Associates, L.L.C.) announces an affiliation with Dr. Jane Rohlf and Premier Research, of Trenton, New Jersey. “Dr. Rohlf brings wealth of research expertise and her site fit well into our strategic plan to offer Biopharmaceutical Industry a broad... - May 24, 2014 - Wake Research Associates

Northeastern M.D.s to Gather for Presentation by Dr. Emil J. Haldey, Leading Pharmaceutical Compounding Expert

Northeastern M.D.s to Gather for Presentation by Dr. Emil J. Haldey, Leading Pharmaceutical Compounding Expert

The prestigious National Medical Association will host a seminar on Friday featuring Dr. Emil J. Haldey, a doctor of pharmacy and a leader in the specialized field of pharmaceutical compounding. The event will take place May 23, beginning at 2 p.m., during the National Medical Association Annual... - May 22, 2014 - HALDEY Pharmaceutical Compounding

Medcom Kinetics Launches New Web Presence

Medcom Kinetics, Inc., a content and digital applications development company offering services to the pharmaceutical, biotech, and medical devices industries has enhanced its presence on the internet by updating its corporate website’s design, content, and layout, adding a uniquely appealing... - May 18, 2014 - Medcom Kinetics, Inc.

PBS Hightens Security in Prescription Blanks

Security in prescription forms and pads is an industry ridden with fraud and drug diversion. But the prescription blanks approved vendors are fighting back to improve tamper-resistant forms and pads. - May 15, 2014 - PBS - Professional Business Systems

Meeting the Requirements of the Pharmaceutical Supply Chain Initiative Webinar

The Pharmaceutical Supply Chain Initiative (PSCI) is an initiative of the major brands in the pharmaceutical sector. PSCI is a group of pharmaceutical companies that share a vision of improved social, economic and environmental outcome for all stakeholders of the pharmaceutical supply chain, focused particularly on acceptable working conditions, safe process and facilities, economic development and a cleaner environment for local communities. - May 13, 2014 - SGS

PharmSource Lead Sheet's New Platform Adds Functionality, Dynamic Interface

Real-time resource for CROs, CMOs seeking to build market share. - May 10, 2014 - PharmSource

Xcelthera Secures Patent for Large-Scale Production High Quality Human ES Cell Therapy Products

Xcelthera Inc and its joint research partner San Diego Regenerative Medicine Institute announced today that the USPTO has granted Patent No. 8,716,017 entitled “Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells”. - May 08, 2014 - Xcelthera Inc

LUZ Sponsors DA4S East Conference

Minority owned life science translation company continues support of Diversity Alliance for Science event. - May 04, 2014 - LUZ, Inc.

BiologicsCorp Launches Supernatant Protein Expression Service

BiologicsCorp Launches Supernatant Protein Expression Service

BiologicsCorp proudly launches this new service - another first in the industry. They have tested many variables, including codon optimization, strain, charperones and foldases, and others. Give Supernatant Service a try, especially if your protein of interest could not be expressed in soluble form. BiologicsCorp is confident and can guarantee success - no soluble fraction for target protein, no payment for expression service. - April 25, 2014 - BiologicsCorp

CRO Analytics Announces Free Webinar on the Use of Validated Analytics to Improve Clinical Trial Management

This free webinar will be held on Wednesday, May 14, 10AM EST. - April 18, 2014 - CRO Analytics

Clinigen Group to Manage International Named Patient Program for Abiogen Pharma’s Nerixia® (Neridronic Acid)

Clinigen Group plc (‘Clinigen’ or the ‘Group’) (AIM: CLIN) and Abiogen Pharma SpA (‘Abiogen’) jointly announced today the initiation of a Named Patient Program, managed by Clinigen Global Access Programs (Clinigen GAP) to provide Nerixia® (neridronic acid),... - April 16, 2014 - Clinigen Group

Recursion Pharmaceuticals Announces Formation of Its Scientific and Technical Advisory Board

Recursion Pharmaceuticals is a start-up biotech firm in Salt Lake City with a goal of discovering new therapeutics for the treatment of rare genetic diseases. Recursion announced the formation of its Scientific and Technical Advisory Board today, along with the appointment of Dr. Anne Carpenter and Dr. Kirk Thomas as its first two members. - April 12, 2014 - Recursion Pharmaceuticals

Pharmacovigilance Market is Expected to Reach USD 5.0 Billion Globally in 2019: Transparency Market Research

Transparency Market Research Report Adds "Pharmacovigilance Market Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database. - April 12, 2014 - Transparency Market Research

Lucideon to Open Pharmaceutical Laboratories

Lucideon is pleased to announce that it has invested £1.5M in new pharmaceutical chemistry quality control (QC) testing laboratories, at its headquarters in Stoke-on-Trent. - April 10, 2014 - Lucideon

Dr. Kristy Ainslie Strengthens Drug Delivery Focus as She Becomes Advisor to Peptineo

Peptineo is pleased to welcome Dr. Ainslie to advisory board at Peptineo. Dr. Ainslie received her PhD in Chemical Engineering from Penn State, and after a short post doc in a start up company focused on biosensor development, Protiveris, she completed a post doc at UCSF. During her post doc, she... - April 08, 2014 - Peptineo

New Discussion Topics, New Speakers on Agenda for 3rd Annual Pharmaceutical Managed Markets & Payer Marketing Strategies Conference

Session Topics Include Progression of Medicare Programs and Streamlining Medical Benefit Management Process - April 05, 2014 - Q1 Productions

ALPCO Expands EuroFlow™ Product Offering with the Addition of Plasma Cell Dyscrasias Screening Tube

ALPCO Expands EuroFlow™ Product Offering with the Addition of Plasma Cell Dyscrasias Screening Tube

ALPCO has expanded EuroFlow™ product offering with addition of the Plasma Cell Screening Tube from Cytognos S.L. - April 03, 2014 - ALPCO

Global Endocrine Testing Market Projected to Reach USD 2.03 Billion by 2019: Transparency Market Research

Transparency Market Research has added a new report titled “Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” to its... - April 03, 2014 - Transparency Market Research

OsoBio Appoints Catherine Buck Director of Manufacturing

Buck has 20-plus years of experience managing pharma and commercial manufacturing plants. - April 02, 2014 - OSO BioPharmaceuticals Manufacturing, LLC

Peptineo Adds Dr. Yoganathan to Advisory Board to Strengthen Biomaterials Development and Commercialization

Dr. Yoganathan is a SME in the areas of biomaterials and drug delivery - having collaborated and worked closely with thought-leaders in the field such as Dr. Robert Langer, Dr. Kazunori Kataoka, Dr. Michael V. Sefton and Dr. Christine Allen. He is an expert in manipulating material properties to... - March 31, 2014 - Peptineo

Revolutionary Science Teaching Model Transforms Diabetes HbA1c Blood Test Into Hand-Held Education

Biologic Designs launches first crowdfunding campaign to introduce its latest educational product, the Glycated Hemoglobin A1c (HbA1c) Teaching Model. The biologic protein marker from the HbA1c blood test is no longer just a number; it is a physiological process that can be demonstrated to patients through tactile science education. - March 29, 2014 - Biologic Designs LLC

Summit Biosciences Announces Successful FDA Preapproval Inspection for Manufacturing of Nasal Spray Drug Product

Summit Biosciences Inc., a specialty pharmaceutical company, is pleased to announce that the manufacturing facility in Lexington, Kentucky has successfully passed its first preapproval inspection by the Food and Drug Administration (FDA). The inspection for a new nasal spray drug product, which... - March 28, 2014 - Summit Biosciences Inc.

Peptineo Announces Appointment of David M. Wyatt to Advisory Board

Peptineo is pleased to announce the appointment of David M. Wyatt to their advisory board. David has had over 25 years of technical and business experience in the development of controlled release pharmaceutical products. He has held senior management positions in sales and business development,... - March 27, 2014 - Peptineo

New Location, New Speakers Set for 3rd Annual Strengthening Patient Advocacy Relations Across the Life Sciences Conference

Partnering with PCORI, Building Effective Industry Alliances, Utilizing Non-Branded Patient Websites Among Discussion Topics. - March 21, 2014 - Q1 Productions

OnkoDataMed Joins ACM, ICRC-Weyer in Medis Research Group

Medis Research Group, a strategic alliance of Berlin-based clinical research organizations, has recently been joined by yet another CRO from the Berlin area, oncology specialists OnkoDataMed GmbH. - March 19, 2014 - ICRC-Weyer GmbH

White Paper: The Hazards of Unapproved Drugs and Importance of Utilizing Approved Drugs

“Continued use of non-approved drugs when a safe, FDA-approved product is available is not in the public interest and can lead to legal lawsuits.” -Cindy Ippoliti, Pharm.D., NYP/Weill Cornell - March 17, 2014 - Expect Advertising, Inc.

Annodyne Announces the Launch of Its New Division: AIM Rx

AIM Rx is a new full-service digital health care agency with a concentrated focus on complex specialty markets. - March 09, 2014 - Annodyne, Inc.

Disruptive Innovation in Clinical Trials

Disruptive Innovation in Clinical Trials

Dataline Software is delighted to announce its attendance at the inaugural "Disruptive Innovation in Clinical Trials" conference in London on 4th & 5th March 2014, where it will be showcasing its latest eClinical solutions. Introducing TrialViz; Trial feasibility and recruitment. At... - March 01, 2014 - Dataline Software

Robert M. Adams Recognized by Strathmore's Who's Who Worldwide Publication

Robert M. Adams Recognized by Strathmore's Who's Who Worldwide Publication

Robert M. Adams of Las Vegas, Nevada has been included in the Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of law. About Robert M. Adams Mr. Adams is a Partner with the law firm of Eglet Wall Christiansen, and has over 15... - March 01, 2014 - Strathmore Worldwide

Triad to Provide Global Investment Banking for the Healthcare Industry

Triad Securities, a leading Wall St brokerage firm, is pleased to announce the formation of Triad Healthcare Partners, a division of Triad Securities Corp. The new division, headed by Andrew Hirschberg, will provide investment banking services, focused on the specialty pharmaceutical sector. - February 28, 2014 - Triad Securities

New Drug Safety/Pharmacovigilance Report Training by Well-Known Safety Expert

Drug Safety Navigator, LLC will proudly host an interactive drug safety webinar with Dr. Barton Cobert, global pharmacovigilance expert and published author, on the challenges of the new Periodic Benefit-Risk Evaluation Reports (PBRERs) on March 26 at 11:00 AM EST (USA). - February 28, 2014 - Drug Safety Navigator, LLC

Melissa Easy, Founder of DrugDev Selected as a Finalist for IIR Partnerships Woman of the Year

IIR’s Partnerships in Clinical Trials named Melissa Easy, founder of DrugDev as a finalist for the IIR Partnerships Woman of the Year Award. The award was created to honor exceptional women in the clinical trials industry who have successfully achieved the highest levels of professional... - February 28, 2014 - Clinical Financial Services

Crack the Code: Demystify the Success Factors for Career Development

Sino-American Pharmaceutical Professional Associations (SAPA) will hold the 2014 Career Development Workshop: “Crack the Code: Demystify the Success Factors for Career Development” on Saturday, March 1st, 2014, 9 am - 5 pm at the Rutgers University (675 Hoes Lane West, Piscataway, New... - February 22, 2014 - Sino-American Pharmaceutical Professionals Association

IMAPAC’s 3rd Biologics Korea Gathering to Bring Together Over 150 Leading Industry Players

With support from the Korean Biologics Manufacturers Association (KPMA), IMAPAC will organize the 3rd Annual Biologics World Korea 2014 conference to take place from 22-24 April 2014, in Seoul, Korea. - February 21, 2014 - IMAPAC

Strathmore’s Who’s Who Names Mario C. Calanna the Mentor of the Year 2014

Strathmore’s Who’s Who Names Mario C. Calanna the Mentor of the Year 2014

Mario C. Calanna, of Woree, Queensland, Australian, has been named the Mentor of the Year by Strathmore’s Who’s Who Registry for providing advice, information and support in Total Health Solutions. - February 20, 2014 - Strathmore Who's Who

Metrics Inc. Expands with Fast-Track Pharmaceutical Product Development Laboratory

Along with Gerteis Mini-Pactor®, capital investments reflect ongoing commitment to contract services - February 20, 2014 - Metrics, Inc.

Press Releases 1,501 - 1,550 of 2,704